Stockreport

Achaogen Highlights Multiple Plazomicin Presentations at ESCMID/ASM 2018 Conference

ACHAOGEN  (AKAO) 
Last achaogen earnings: 3/28 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.achaogen.com/investor-overview
PDF SOUTH SAN FRANCISCO, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company developing innovative antibacterials address [Read more]